CIO Jimmy Hanson talks about the importance of cybersecurity and how we protect our clients, providers, and members.

Knock offs or the real deal? Long known to be safe, effective and approved by the Food and Drug Administration (FDA), generics now make up 80 percent of all prescriptions filled.

Biosimilars, medical products that are highly similar to other already approved biological medicines, are gaining momentum as a way to improve outcomes and lower costs.

This debilitating neurological disease affects 39 million people in the U.S. yet migraines are often downplayed as simply just a headache.

IPM’s CFO Kurt Belluomini breaks down the various stakeholders, the role they play in pricing, and how we help our clients achieve their clinical and financial goals.

Alternate funding has evolved in recent years as a way to help employers match specialty drug costs with funding. Check out this video by our president and chief operating officer, Rich Adams, to learn more.

IPM offers game-changing employee benefit for depression and anxiety.

IPM is proud to have NINE staffers launch their careers as front desk receptionists and go on to hold numerous positions within our organization. Now that’s a success story worth sharing!

In this Forbes piece, IPM's President and COO Rich Adams examines the role of PBMs and what the future holds in this dynamic industry.